Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
Clinical trial NCT03532737 · UNKNOWN
Trial details
- NCT number
- NCT03532737
- Sponsor
- Kuwait Cancer Control Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-07
- Primary completion
- 2025-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.